News und Analysen
Cantel Medical Corp. Keeps Pace on Its Goal
Cantel Medical (NYSE: CMD) reported results for the first quarter, posting double-digit revenue and earnings growth to start its fiscal year. It's hard to ask for more from the medical-supply....
Cantel Medical (CMD) Q1 2018 Earnings Conference Call Transcript
Image source: The Motley Fool.Cantel Medical (NYSE: CMD) Q1 2018 Earnings Conference CallDec. 7, 2017 11:00 a.m. ETOperatorContinue readingSource: Fool.com
Why DaVita Inc. Jumped Higher Today
DaVita (NYSE: DVA) is up 12.8% at 12:35 p.m. EST after announcing that it's selling its medical group to UnitedHealth Group's (NYSE: UNH) health services business Optum for $4.9 billion.....
Can Teladoc Stock Keep Going After Last Week's 24% Pop?
One of last week's biggest winners makes house calls. Teladoc (NYSE: TDOC) soared 24.1% last week, making it the second best performer on the New York Stock Exchange. Teladoc moved higher after....
5 Lesser-Known Rule Breakers: Where We Stand at the 2-Year Mark
On this week's Rule Breaker Investing podcast, Motley Fool co-founder David Gardner reviews the performance of a set of his stock picks made up of companies most folks won't have heard of.Based on....
A Big Hedge Fund Is Behind Mednax Soaring 12.7% Today
Shares of Mednax (NYSE: MD) were up 12.7% at 3:30 p.m. EST Thursday after Paul Singer's Elliott Management revealed a 7% stake in the company and agreed to speak to management about ways to boost....
5 Supernova Stocks That Have Flown Under the Radar: NuVasive
Last week on the Rule Breaker Investing podcast, Motley Fool co-founder David Gardner reviewed the performance of two sets of his buy-and-hold stock picks: one set with a five-year horizon, and....
5 Supernova Stocks That Have Flown Under the Radar
Recently on the Rule Breakers Investing podcast, Motley Fool co-founder David Gardner reviewed the performance of two sets of his buy-and-hold stock picks: one set with a five-year horizon, and....
Globus Medical Inc. Posts Solid 3rd-Quarter Results With Robots in Its Future
Globus Medical Inc. (NYSE: GMED) shareholders had to love the first half of 2017. The musculoskeletal-solutions company saw its stock price soar more than 30% by late June. Since then, Globus....
Is This Why Glaukos Corp. Is Tumbling Today?
Shares of Glaukos (NYSE: GKOS), a medical-device company focused on glaucoma, fell 12% as of 3:25 p.m. EST on Tuesday on heavy volume. However, there wasn't any news that can help to explain the
Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16%....
Insulet Posts 28% Revenue Growth and Raises 2017 Outlook on Soaring International Sales
Insulet (NASDAQ: PODD) reported solid third-quarter 2017 financial results after the market closed on Thursday. The drug delivery company, which is a leader in tubeless insulin pump technology....
Here's Why Myriad Genetics Dropped as Much as 18.6%
Shares of genetic-testing leader Myriad Genetics (NASDAQ: MYGN) dropped over 18% today. That may have investors confused, especially considering the company today announced that its GeneSight....
Masimo Corporation's Mighty Momentum Continues in 3rd Quarter
Things looked so great for Masimo Corporation (NASDAQ: MASI) when it reported results from the second quarter in August that the company upped its full-year guidance. Revenue and earnings soared,....
Here's Why NuVasive, Inc. Popped Today
Shares of NuVasive, Inc. (NASDAQ: NUVA), a spinal-surgery device manufacturer, popped as high as 9.8% Wednesday morning before settling back down to an 8.1% gain as of 3:07 p.m. A mixed....
Here's Why Acadia Healthcare Company Inc. Is Sinking Today
Shares of Acadia Healthcare Company Inc. (NASDAQ: ACHC) have fallen 25.6% as of 11:01 a.m. EDT on Wednesday after the company reported softer-than-expected results on Tuesday. The provider....
NuVasive's Sluggish Sales Growth Prompts Buybacks
Modern medicine has offered some revolutionary products and techniques, and many companies are looking to help sustain the pace of medical advances. NuVasive's (NASDAQ: NUVA) specialty in spinal....
3 Growth Stocks at Value Stock Prices
It's not surprising that after an eight-year bull market, some are saying value investing is dead. With the cyclically adjusted P/E ratio of the S&P running at a red-hot 31, finding a value....
3 Signs Myriad Genetics' High-Growth Days Are Over
Myriad Genetics (NASDAQ: MYGN) used to be the creme de la creme of the genetic testing industry. It had healthy profit margins, a growing business, and was well-known among investors and health....
Why Viacom, DaVita, and K2M Group Holdings Slumped Today
Monday was a down day on Wall Street, with the Dow, S&P 500, and Nasdaq Composite all giving up between 0.1% and 0.2%. The trading session was relatively quiet on the Columbus Day holiday,....
Cantel Medical Corp. Closes Out the Year With a Solid Mix of Growth
Cantel Medical (NYSE: CMD) closed out its fiscal year that ended in July with a solid fourth quarter and looks to build on the year with impressive guidance for the fiscal year ahead. Here's a....
Masimo Corporation Fell 12.7% in August -- but Why?
Shares of Masimo Corporation (NASDAQ: MASI), a medical-device company focused on noninvasive testing equipment, fell by more than 12% in August, according to data from S&P Global Market....
The 2 Major Catalysts Behind Myriad Genetics, Inc.'s 26% Gain in August
Shares of Myriad Genetics (NASDAQ: MYGN), a leading developer of molecular diagnostic tests, surged by 26% during the month of August, according to data from S&P Global Market Intelligence.....
Why Tenet Healthcare Shares Are Rallying 14.2% Today
After a sell-off that's seen its shares drop from over $20 in July to below $13 earlier this month, news that a hedge fund has acquired a 5.7% stake sent shares of Tenet Healthcare (NYSE:....
Why Calpine, Tenet Healthcare, and Snap Jumped Today
Stocks closed down on Friday, as major benchmarks failed to make back lost ground from Thursday's steep declines. The departure of Trump administration chief strategist Stephen Bannon marked the....